Novartis Animal Health UK Announce Commitment To Provide A Reliable Supply Of BVD Vaccine

Novartis Animal Health UK announce commitment to provide a reliable supply of BVD vaccine

• Novartis Animal Health UK Ltd today announce a commitment to provide a reliable supply of Bovidec® BVD Virus vaccine
• Bovidec® BVD virus vaccine indicated for active immunization of female breeding cattle as an aid to prevention of infection with BVD Type I virus
• Novartis Animal Health positioned to provide comprehensive technical support at start of vaccination season

Frimley, Sept 20 2010 — Novartis Animal Health UK today announced a commitment to maintaining a reliable supply of Bovidec® BVD virus vaccine throughout the coming season. Recent concerns surrounding the availability of BVD vaccines prompted the comment from Novartis Brand Manager Eugene Smyth. “We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months” he said. Mr Smyth added that “We have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season”. Bovidec® BVD virus vaccine, actively immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus and was the first commercially available BVD vaccine. Advice on the use of Bovidec® BVD virus vaccine must be sought from a veterinarian.

More from

• Vetsure Named Business of the Year at 2025 SME National Business Awards
• Home of hope for Romania's dogs: The pioneering shelter doing things differently
• Pioneering new locum platform transforming veterinary landscape
• Key Stakeholders unite to advance helmet design for equine veterinary professionals
• Hallmarq hails transformational equine imaging technology